Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
marina.borro@uniroma1.it
Marina Borro
Professore Associato
Struttura:
DIPARTIMENTO DI NEUROSCIENZE, SALUTE MENTALE E ORGANI DI SENSO
E-mail:
marina.borro@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Personalized medicine applied to forensic sciences: new advances and perspectives for a tailored forensic approach
CURRENT PHARMACEUTICAL BIOTECHNOLOGY
2017
Clinical applications of personalized medicine: a new paradigm and challenge
CURRENT PHARMACEUTICAL BIOTECHNOLOGY
2017
A nomogram to predict 5-fluorouracil toxicity: when pharmacogenomics meets the patient
ANTI-CANCER DRUGS
2017
Personalised healthcare: the DiMA clinical model
CURRENT PHARMACEUTICAL BIOTECHNOLOGY
2017
Pre-treatment evaluation of 5-fluorouracil degradation rate. association of poor and ultra-rapid metabolism with severe toxicity in a colorectal cancer patients cohort
ONCOTARGET
2016
CYP19A1 Genetic Polymorphisms rs4646 and Osteoporosis in Patients Treated with Aromatase Inhibitor-Based Adjuvant Therapy
THE EURASIAN JOURNAL OF MEDICINE
2016
Choosing the safest acute therapy during chronic migraine prophylactic treatment. pharmacokinetic and pharmacodynamic considerations
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY
2016
H2020 and beyond: skip discrepancy between theory and practice of personalized medicine. A position paper by the italian society of personalized medicine
CURRENT PHARMACEUTICAL BIOTECHNOLOGY
2016
Pre-treatment assay of 5-fluorouracil degradation rate (5-FUDR) to improve prediction of 5-fluorouracil toxicity in gastro-esophageal cancer
ONCOTARGET
2016
Degradation rate of 5-fluorouracil in metastatic colorectal cancer. A new predictive outcome biomarker?
PLOS ONE
2016
Precise medical decision making in geriatric anti-depressant therapy
EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT
2016
5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOX
ANTI-CANCER DRUGS
2016
Potential role of single nucleotide polymorphisms of XRCC1, XRCC3, and RAD51 in predicting acute toxicity in rectal cancer patients treated with preoperative radiochemotherapy
AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS
2015
Lack of association between oxidative stress-related gene polymorphisms and chronic migraine in an Italian population
EXPERT REVIEW NEUROTHERAPEUTICS
2015
Genotype–phenotype correlations in 5-fluorouracil metabolism. a candidate DPYD haplotype to improve toxicity prediction
PHARMACOGENOMICS JOURNAL
2015
Effect of MTHFR polymorphisms on gastrointestinal cancer risk in Italy
WORLD JOURNAL OF ONCOLOGY
2015
FCGRs Polymorphisms and Response to Trastuzumab in Patients With HER2-Positive Breast Cancer: Far From Predictive Value?
WORLD JOURNAL OF ONCOLOGY
2015
« prima
< precedente
1
2
3
Progetti di Ricerca
Exploring genetic determinants of increased activity of Dihydro-Pyrimidine Dehydrogenase to dissect mechanisms underlying the inter-individual variability in response to the anti-cancer drug 5-Fluorouracil
Association study between development of Chronic Obstructive Pulmonary Disease and the individual rate of nicotine clearance in smokers
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma